In this activity interprofessional panel of experts engage in a case-based discussion focused on the management of nonmotor symptoms in patients with Parkinson’s disease (PD). The implementation of interprofessional care and collaboration to provide an optimal experience for an individuals with PD is emphasized by the panel. They also share their insights on various treatment approaches for nonmotor symptoms. Participate in this educational activity today!
Launched July 30, 2021
Upon successful completion of this education activity, participants should be better able to:
Adelaide Lackner Professor and Chair of Neurology
Executive Director, Norman Fixel Institute for Neurological Diseases
University of Florida Health
Norman Fixel Institute for Neurological Diseases
University of Florida Health
Board Certified Neurologic Physical Therapist
UF Health Rehab Center – Norman Fixel Institute for Neurological Diseases
RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy. RMEI is committed to providing its learners with high-quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
Michael S. Okun, MD, Alison Kraus, PT, DPT, NCS, and Janet Romrell, PA-C have no relevant financial relationship(s) with ineligible companies to disclose.
RMEI Medical Education, LLC planners and managers have no relevant financial relationship(s) with ineligible companies to disclose.
All of the relevant financial relationships listed for these individuals have been mitigated according to RMEI policies.
RMEI Medical Education, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.50 contact hours.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
In order to receive credit, participants must review the activity content and successfully complete both the post-test and evaluation. You must score 75% or higher on the post-test to receive credit for this activity.
If you have questions about this activity, please contact RMEI at [email protected].
There is no fee to participate.
Featured RMEI CE Activities